Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Molecular Neurobiology|October 5, 2021
α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic HallmarksÁngel Juan García-Yagüe, Isabel Lastres-Becker, Leonidas Stefanis, et al.Neurotoxicity Research|April 24, 2003
Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's diseaseIsabel Lastres-Becker, María Gómez, Rosario De Miguel, et al.Neurobiology of Disease|April 20, 2005
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's diseaseIsabel Lastres-Becker, Francisco Molina-Holgado, José A Ramos, et al.The Journal of Biological Chemistry|January 4, 2013
Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stressÁngel Juan García-Yagüe, Patricia Rada, Ana I Rojo, et al.Brain Research|April 6, 2004
Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidenceEva de Lago, Rosario de Miguel, Isabel Lastres-Becker, et al.Glia|September 2, 2011
Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatumNoelia Granado, Isabel Lastres-Becker, Sara Ares-Santos, et al.Human Molecular Genetics|April 20, 2012
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's diseaseIsabel Lastres-Becker, Ayse Ulusoy, Nadia G Innamorato, et al.Pharmacology & Therapeutics|August 17, 2002
The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspectsJulián Romero, Isabel Lastres-Becker, Rosario de Miguel, et al.Brain : a Journal of Neurology|November 27, 2013
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosisIsabel Lastres-Becker, Nadia G Innamorato, Tomasz Jaworski, et al.Journal of Neurochemistry|February 27, 2003
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's diseaseIsabel Lastres-Becker, Rosario de Miguel, Luciano De Petrocellis, et al.Pageof 6